2019
DOI: 10.1038/s41467-019-10262-5
|View full text |Cite
|
Sign up to set email alerts
|

Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence

Abstract: Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccination strategies aimed at inducing broadly neutralizing antibodies (bNAbs). To limit the exposure of rare isolate-specific antigenic residues/determinants we generated a SOSIP trimer based on a consensus sequence of all HIV-1 group M isolates (ConM). The ConM trimer displays the epitopes of most known bNAbs and several germline bNAb precursors. The crystal structure of the ConM trimer at 3.9 Å resolution resembles … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
191
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 132 publications
(197 citation statements)
references
References 80 publications
6
191
0
Order By: Relevance
“…A multitude of broadly neutralizing antibodies (bNAbs) have now been characterized, targeting various sites on HIV-1 Env (Haynes and Mascola, 2017;Sok and Burton, 2018). Structures of these bNAbs in complex with Env have paved the way for structure-based vaccine design by facilitating the identification of stabilizing mutations that allow large scale expression and purification of the unliganded ectodomain (Dey et al, 2018;Guenaga et al, 2017;Joyce et al, 2017;Klein et al, 2013;Kulp et al, 2017;Kwon et al, 2015;Ringe et al, 2017;Rutten et al, 2018;Schoofs et al, 2019;Sliepen et al, 2019;Torrents de la Pena and Sanders, 2018;Ward and Wilson, 2017;Yuan et al, 2019). The epitopes of MPER-targeting bNAbs were however truncated along with TMD and CTD from almost all of these Envs to increase solubility and stability and, therefore, remains perhaps the least understood epitope.…”
Section: Introductionmentioning
confidence: 99%
“…A multitude of broadly neutralizing antibodies (bNAbs) have now been characterized, targeting various sites on HIV-1 Env (Haynes and Mascola, 2017;Sok and Burton, 2018). Structures of these bNAbs in complex with Env have paved the way for structure-based vaccine design by facilitating the identification of stabilizing mutations that allow large scale expression and purification of the unliganded ectodomain (Dey et al, 2018;Guenaga et al, 2017;Joyce et al, 2017;Klein et al, 2013;Kulp et al, 2017;Kwon et al, 2015;Ringe et al, 2017;Rutten et al, 2018;Schoofs et al, 2019;Sliepen et al, 2019;Torrents de la Pena and Sanders, 2018;Ward and Wilson, 2017;Yuan et al, 2019). The epitopes of MPER-targeting bNAbs were however truncated along with TMD and CTD from almost all of these Envs to increase solubility and stability and, therefore, remains perhaps the least understood epitope.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, many studies have succeeded in stabilizing the closed conformation of the HIV-1 Env both in the soluble Env format, as well on the cell surface, with varying levels of success in eliciting autologous and heterologous neutralization. 1021…”
Section: Discussionmentioning
confidence: 99%
“…Centroids for the vectors in the analysis included a K46-K490 Cα centroid, W571 and W596 c-αs, c-αs of gp120 excluding variable loops the V1/V1 region residues, and the N- and C-termni, and a V1/V2+V3 c-α centroid Vectors between these reference positions were generated and included a projection of the W596 to K46-K490 centroid vector on to the W596 to W571 vector. Angles, distances, and dihedrals between these vectors were then compiled for a set of available crystal and cryo-EM structures with PDB IDs 4TVP 71 , 4ZMJ 25 , 5ACO 72 , 5CEZ 37 , 5CJX 73 , 5D9Q 74 , 5FYJ 75 , 5FYK 75 , 5FYL 75 , 5T3X 76 , 5T3Z 76 , 5U7M 33 , 5U7O 33 , 5UTF 13 , 5V7J 77 , 5V8L 78 , 5V8M 78 , 6CDE 38 , 6CDI 38 , 6CH7 79 , 6CH8 79 , 6CUE 80 , 6CUF 81 , and 6DE7 12 , 5THR 26 , 5VN3 27 , 5VN8 73 , 6CM3 31 , 6EDU 31 , 5FUU 82 , 6DCQ 46 , 6MAR 83 , 5U1F 55 , 5C7K 84 , 5I8H 85 , 5UM8 86 , 5UTY 13 , 5VIY 87 , 5VJ6 87 , 5WDU 14 , 6B0N 88 , 6CCB 89 , 6CE0 11 , 6CH9 79 , 6CHB 79 , 6CK9 90 , 6DCQ 46 , 6DID 91 , 6E5P 92 , 6IEQ 93 , 6MCO 94 , 6MDT 94 , 6MN7 95 , 6MPG 96 , 6MPH 96 , 6MTJ 97 , 6MTN 97 , 6MU6 97 , 6MU7 97 , 6MU8 97 , 6MUF 97 , 6MUG 97 , 6N1V 96 , 6N1W 96 , 6NC2 98 , 6NC3 98 , 6NF2 96 , 6NIJ 47 , 6NM6 99 , 6NNF 99 , 6NNJ 99 , 6OHY 100 , 6OKP 101 , 6OLP 47 , 6ORN 39 , 6ORO 39 , 6OR...…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…bnAbs target the envelope glycoprotein (env) of HIV-1 within defined epitopes, though inferred germlines (iGLs) of several bnAbs do not bind to most of the difficult-to-neutralize HIV-1 isolate. Identification and/or engineering of env variants capable of engaging and shepherding bnAb development pathway are a key focus of lineage-based vaccine approach (812).…”
Section: Introductionmentioning
confidence: 99%